These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 36181056)

  • 1. Curcuminoids can prevent post-contrast acute kidney injury in chronic kidney disease patients: A randomized controlled trial.
    Jaturapisanukul S; Kurathong S; Ngamvichchukorn T; Trakarnvanich T
    Medicine (Baltimore); 2022 Sep; 101(39):e30753. PubMed ID: 36181056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Curcuminoids on Contrast-Induced Acute Kidney Injury after Elective Coronary Angiography or Intervention: A Pilot Randomized, Double-Blind, Placebo-Controlled Study.
    Noppakun K; Jitraknatee J; Suteeka Y; Ruengorn C; Nochaiwong S; Gunaparn S; Phrommintikul A; Wongcharoen W
    Cardiorenal Med; 2024; 14(1):160-166. PubMed ID: 38350427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New strategy of α- and γ-tocopherol to prevent contrast-induced acute kidney injury in chronic kidney disease patients undergoing elective coronary procedures.
    Tasanarong A; Vohakiat A; Hutayanon P; Piyayotai D
    Nephrol Dial Transplant; 2013 Feb; 28(2):337-44. PubMed ID: 23314316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Usefulness of N-acetylcysteine or ascorbic acid versus placebo to prevent contrast-induced acute kidney injury in patients undergoing elective cardiac catheterization: a single-center, prospective, randomized, double-blind, placebo-controlled trial.
    Brueck M; Cengiz H; Hoeltgen R; Wieczorek M; Boedeker RH; Scheibelhut C; Boening A
    J Invasive Cardiol; 2013 Jun; 25(6):276-83. PubMed ID: 23735352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short-Term High-Dose Vitamin E to Prevent Contrast Medium-Induced Acute Kidney Injury in Patients With Chronic Kidney Disease Undergoing Elective Coronary Angiography: A Randomized Placebo-Controlled Trial.
    Rezaei Y; Khademvatani K; Rahimi B; Khoshfetrat M; Arjmand N; Seyyed-Mohammadzad MH
    J Am Heart Assoc; 2016 Mar; 5(3):e002919. PubMed ID: 27068631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post-contrast acute kidney injury in a hospitalized population: short-, mid-, and long-term outcome and risk factors for adverse events.
    Cheng W; Wu X; Liu Q; Wang HS; Zhang NY; Xiao YQ; Yan P; Li XW; Duan XJ; Peng JC; Feng S; Duan SB
    Eur Radiol; 2020 Jun; 30(6):3516-3527. PubMed ID: 32080754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute kidney injury following coronary angiography: a nationwide study of incidence, risk factors and long-term outcomes.
    Helgason D; Long TE; Helgadottir S; Palsson R; Sigurdsson GH; Gudbjartsson T; Indridason OS; Gudmundsdottir IJ; Sigurdsson MI
    J Nephrol; 2018 Oct; 31(5):721-730. PubMed ID: 30187381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short-term rosuvastatin therapy for prevention of contrast-induced acute kidney injury in patients with diabetes and chronic kidney disease.
    Han Y; Zhu G; Han L; Hou F; Huang W; Liu H; Gan J; Jiang T; Li X; Wang W; Ding S; Jia S; Shen W; Wang D; Sun L; Qiu J; Wang X; Li Y; Deng J; Li J; Xu K; Xu B; Mehran R; Huo Y
    J Am Coll Cardiol; 2014 Jan 7-14; 63(1):62-70. PubMed ID: 24076297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Association between Dapagliflozin Use and the Risk of Post-Contrast Acute Kidney Injury in Patients with Type 2 Diabetes and Chronic Kidney Disease: A Propensity-Matched Analysis.
    Liu T; Jian X; Li L; Chu S; Fan Z
    Kidney Blood Press Res; 2023; 48(1):752-760. PubMed ID: 37980899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Left ventricular end-diastolic pressure-guided hydration for the prevention of contrast-induced acute kidney injury in patients with stable ischemic heart disease: the LAKESIDE trial.
    Marashizadeh A; Sanati HR; Sadeghipour P; Peighambari MM; Moosavi J; Shafe O; Firouzi A; Zahedmehr A; Maadani M; Shakerian F; Kiani R; Mohebbi B; Alemzadeh-Ansari MJ; Tahvili R; Naghavi B
    Int Urol Nephrol; 2019 Oct; 51(10):1815-1822. PubMed ID: 31332700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Minimizing radiographic contrast administration during coronary angiography using a novel contrast reduction system: A multicenter observational study of the DyeVert™ plus contrast reduction system.
    Gurm HS; Mavromatis K; Bertolet B; Kereiakes DJ; Amin AP; Shah AP; Hanzel GS; Rao S; Thomas JL; Kumar G
    Catheter Cardiovasc Interv; 2019 Jun; 93(7):1228-1235. PubMed ID: 30393942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Remote Ischemic Conditioning for Preventing Contrast-Induced Acute Kidney Injury in Patients Undergoing Percutaneous Coronary Interventions/Coronary Angiography: A Meta-Analysis of Randomized Controlled Trials.
    Bei WJ; Duan CY; Chen JY; Wang K; Liu YH; Liu Y; Tan N
    J Cardiovasc Pharmacol Ther; 2016 Jan; 21(1):53-63. PubMed ID: 26112028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subclinical and clinical contrast-induced acute kidney injury: data from a novel blood marker for determining the risk of developing contrast-induced nephropathy (ENCINO), a prospective study.
    Akrawinthawong K; Ricci J; Cannon L; Dixon S; Kupfer K; Stivers D; Alexander P; David S; McCullough PA
    Ren Fail; 2015 Mar; 37(2):187-91. PubMed ID: 25519207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Remote Ischemic Preconditioning for the Prevention of Contrast-Induced Acute Kidney Injury in Diabetics Receiving Elective Percutaneous Coronary Intervention.
    Balbir Singh G; Ann SH; Park J; Chung HC; Lee JS; Kim ES; Choi JI; Lee J; Kim SJ; Shin ES
    PLoS One; 2016; 11(10):e0164256. PubMed ID: 27723839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of renal function on patients with acute coronary syndromes: 15,593 patient-years study.
    Kuźma Ł; Małyszko J; Kurasz A; Niwińska MM; Zalewska-Adamiec M; Bachórzewska-Gajewska H; Dobrzycki S
    Ren Fail; 2020 Nov; 42(1):881-889. PubMed ID: 32862755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors and safe contrast volume thresholds for postcontrast acute kidney injury after peripheral vascular interventions.
    Lee SR; Zhuo H; Zhang Y; Dahl N; Dardik A; Ochoa Chaar CI
    J Vasc Surg; 2020 Aug; 72(2):603-610.e1. PubMed ID: 31843298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of a Contrast Modulation System on Contrast Media Use and the Rate of Acute Kidney Injury After Coronary Angiography.
    Mehran R; Faggioni M; Chandrasekhar J; Angiolillo DJ; Bertolet B; Jobe RL; Al-Joundi B; Brar S; Dangas G; Batchelor W; Prasad A; Gurm HS; Tumlin J; Stone GW
    JACC Cardiovasc Interv; 2018 Aug; 11(16):1601-1610. PubMed ID: 30139467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary Neutrophil Gelatinase-Associated Lipocalin predicts the severity of contrast-induced acute kidney injury in chronic kidney disease patients undergoing elective coronary procedures.
    Tasanarong A; Hutayanon P; Piyayotai D
    BMC Nephrol; 2013 Dec; 14():270. PubMed ID: 24305547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kidney Injury after Intravenous versus Intra-arterial Contrast Agent in Patients Suspected of Having Coronary Artery Disease: A Randomized Trial.
    Schönenberger E; Martus P; Bosserdt M; Zimmermann E; Tauber R; Laule M; Dewey M
    Radiology; 2019 Sep; 292(3):664-672. PubMed ID: 31264950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous versus oral hydration to reduce the risk of postcontrast acute kidney injury after intravenous contrast-enhanced CT in patients with severe chronic kidney disease (ENRICH): a study protocol for a single-centre, parallel-group, open-labelled non-inferiority randomised controlled trial in Denmark.
    Ravn EJ; Hasific S; Thomassen M; Hjortebjerg R; Bach Laursen K; Diederichsen A; Bistrup C; Øvrehus KA
    BMJ Open; 2023 Sep; 13(9):e074057. PubMed ID: 37699636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.